In terms of the big picture, however, Carl Tobias, a law professor at the University of Richmond said predicting Merck's total legalliability is tricky.
Much of Clark's time will be spent managing the legalliability from a flood of lawsuits related to the withdrawal of the arthritis drug Vioxx, which was linked to heart attacks and strokes.